e-Drug3D

644

PENICILLAMINE


INN
PENICILLAMINE

cas 52-67-5
CLASS

MUSCULO-SKELETAL
ANTIDOTES
ANTIRHEUMATIC AGENTS
CHELATING AGENTS
TREATMENT OF WILSON'S DISEASE
REDUCE CYSTINE EXCRETION IN CYSTINURIA

ROUTE (list)

ORAL

ATC code

M01CC01

PK parameters

F 55 PERCENT
Tmax 2 HOUR
PPB 80 PERCENT
t1/2 4.3 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

-

DrugCentral

Unknown

Download SDF file (2S)-2-amino-3-methyl-3-sulfanylbutanoic acid

Formula:
C5H11NO2S

Calculated chemical properties:

MW 148.21
NB_atoms 9
XLogP -1.23
PSA 55.647
NB_HD 2
NB_HA 3
fsp3 0.80
Lipinski(0=no;1=yes) 1

FDA
NDA 019853 (label) INN (PENICILLAMINE) CUPRIMINE (VALEANT PHARMS INTL) APPROVAL= AP YEAR= 1970
NDA 019854 (pdf not found) INN (PENICILLAMINE) DEPEN (MYLAN SPECIALITY LP) APPROVAL= AP YEAR= 1978
NDA 209921 (pdf not found) INN (PENICILLAMINE) LUXZYLA (ANI PHARMS) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 210976 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (WATSON LABS INC) APPROVAL= AP YEAR= 2019
NDA 211196 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (PH HEALTH) APPROVAL= AP YEAR= 2019
NDA 211231 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (PH HEALTH) APPROVAL= AP YEAR= 2019
NDA 211497 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 213310 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (APOTEX) APPROVAL= AP YEAR= 2020
NDA 211735 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (GRANULES) APPROVAL= AP YEAR= 2020
NDA 211867 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (DR REDDYS) APPROVAL= AP YEAR= 2020
NDA 212933 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (LUPIN LTD) APPROVAL= AP YEAR= 2020
NDA 213293 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (INVAGEN PHARMS) APPROVAL= AP YEAR= 2021
NDA 214363 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (NAVINTA LLC) APPROVAL= AP YEAR= 2021
NDA 215409 (pdf not found) INN (PENICILLAMINE) PENICILLAMINE (BRECKENRIDGE) APPROVAL= AP YEAR= 2021

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL